-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
ProMIS Neurosciences (OTCMKTS:ARFXF) Hits New 12-Month High at $5.80
ProMIS Neurosciences (OTCMKTS:ARFXF) Hits New 12-Month High at $5.80
ProMIS Neurosciences, Inc. (OTCMKTS:ARFXF – Get Rating) hit a new 52-week high on Monday . The stock traded as high as $5.80 and last traded at $5.80, with a volume of 24 shares trading hands. The stock had previously closed at $5.80.
ProMIS Neurosciences Stock Performance
The company has a market capitalization of $2.50 billion, a PE ratio of -10.20 and a beta of 1.08. The company has a quick ratio of 10.37, a current ratio of 10.37 and a debt-to-equity ratio of 1.08. The company has a 50-day moving average price of $5.80 and a two-hundred day moving average price of $5.49.
ProMIS Neurosciences Company Profile
(Get Rating)
ProMIS Neurosciences, Inc discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins.
Recommended Stories
- Get a free copy of the StockNews.com research report on ProMIS Neurosciences (ARFXF)
- Is It Time To Take A Ride With Joby Aviation's EV Innovations?
- After a $100 Haircut, is Catalent an Oversold Pharma Play?
- Is Tyson Foods Too Cheap To Ignore?
- Alphabet Stock Offers a Rare Buying Opportunity
- Walt Disney Stock is Set to Reset Expectations
Receive News & Ratings for ProMIS Neurosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProMIS Neurosciences and related companies with MarketBeat.com's FREE daily email newsletter.
ProMIS Neurosciences, Inc. (OTCMKTS:ARFXF – Get Rating) hit a new 52-week high on Monday . The stock traded as high as $5.80 and last traded at $5.80, with a volume of 24 shares trading hands. The stock had previously closed at $5.80.
PROMIS神经科学公司(OTCMKTS:ARFXF-GET Rating)周一创下52周新高。该股最高交易价格为5.80美元,最新报5.80美元,成交量为24股。该股此前收盘价为5.80美元。
ProMIS Neurosciences Stock Performance
PROMIS神经科学类股表现
The company has a market capitalization of $2.50 billion, a PE ratio of -10.20 and a beta of 1.08. The company has a quick ratio of 10.37, a current ratio of 10.37 and a debt-to-equity ratio of 1.08. The company has a 50-day moving average price of $5.80 and a two-hundred day moving average price of $5.49.
该公司市值为25亿美元,市盈率为-10.20,贝塔系数为1.08。该公司的速动比率为10.37,流动比率为10.37,债务权益比为1.08。该公司的50日移动均线价格为5.80美元,200日移动均线价格为5.49美元。
ProMIS Neurosciences Company Profile
Promis神经科学公司简介
(Get Rating)
(获取评级)
ProMIS Neurosciences, Inc discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins.
Promis神经科学公司发现和开发用于治疗神经退行性疾病的精确医学解决方案,主要是加拿大的阿尔茨海默病(AD)、肌萎缩侧索硬化症(ALS)和多系统萎缩(MSA)。该公司的专有发现平台包括PROMIS和Collective坐标算法,用于预测错误折叠蛋白质分子表面上被称为疾病特异性表位的新靶点。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on ProMIS Neurosciences (ARFXF)
- Is It Time To Take A Ride With Joby Aviation's EV Innovations?
- After a $100 Haircut, is Catalent an Oversold Pharma Play?
- Is Tyson Foods Too Cheap To Ignore?
- Alphabet Stock Offers a Rare Buying Opportunity
- Walt Disney Stock is Set to Reset Expectations
- 免费获取StockNews.com关于Promis神经科学的研究报告(ARFXF)
- 是时候与Joby Aviation的电动汽车创新一起兜风了吗?
- 在100美元的理发之后,Catalent是一个超卖的制药公司吗?
- 泰森食品是不是太便宜了,不容忽视?
- Alphabet股票提供难得的买入机会
- 华特迪士尼股票将重置预期
Receive News & Ratings for ProMIS Neurosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProMIS Neurosciences and related companies with MarketBeat.com's FREE daily email newsletter.
接受PROMIS神经科学日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Promis神经科学和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧